GP

Garrick Packard

SP Signal Pharmaceuticals: 14 patents #18 of 207Top 9%
ET Effector Therapeutics: 4 patents #8 of 24Top 35%
Abbott: 1 patents #3,441 of 5,431Top 65%
📍 San Diego, CA: #2,100 of 23,606 inventorsTop 9%
🗺 California: #28,827 of 386,348 inventorsTop 8%
Overall (All Time): #214,485 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Showing 1–20 of 20 patents

Patent #TitleCo-InventorsDate
12258332 ASGPR cell surface receptor binding compounds and conjugates Brett B. Busch, Justin T. Ernst, Jason G. Lewis, Eric D. Turtle 2025-03-25
11440917 EIF4A-inhibiting compounds and methods related thereto Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Alan X. Xiang +2 more 2022-09-13
11292796 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Patrick Papa +7 more 2022-04-05
11286268 EIF4E-inhibiting compounds and methods Samuel Sperry, Alan X. Xiang, Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler +7 more 2022-03-29
10683298 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Patrick Papa +7 more 2020-06-16
10577378 EIF4A-inhibiting compounds and methods related thereto Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Alan X. Xiang +2 more 2020-03-03
10167290 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Patrick Papa +7 more 2019-01-01
9957277 eIF4A-inhibiting compounds and methods related thereto Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Alan X. Xiang +2 more 2018-05-01
9771371 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Patrick Papa +7 more 2017-09-26
9193692 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2015-11-24
9079900 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2015-07-14
8907087 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +6 more 2014-12-09
8569494 Methods of synthesis and purification of heteroaryl compounds Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +13 more 2013-10-29
8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-08-13
8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2013-07-23
8372976 Methods of treatment comprising the administration of heteroaryl compounds Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2013-02-12
8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Sogole Bahmanyar, R.J. Bates, Kate Blease, Andrew Antony Calabrese, Thomas Oran Daniel +22 more 2012-10-30
8110578 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more 2012-02-07
7981893 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more 2011-07-19
6831175 Kinase inhibitors Qun Li, Keith W. Woods, Gui-Dong Zhu, John P. Fischer, Jianchun Gong +11 more 2004-12-14